AngioDynamics Stock Performance

ANGO Stock  USD 12.07  0.22  1.79%   
The firm shows a Beta (market volatility) of 0.3296, which signifies possible diversification benefits within a given portfolio. Let's try to break down what AngioDynamics's beta means in this case. As returns on the market increase, AngioDynamics returns are expected to increase less than the market. However, during the bear market, the loss on holding AngioDynamics will be expected to be smaller as well. Even though it is essential to pay attention to AngioDynamics historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy in foreseeing any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. AngioDynamics exposes twenty-eight different technical indicators, which can help you to evaluate its performance. AngioDynamics has an expected return of -0.12%. Please be advised to confirm AngioDynamics value at risk, and the relationship between the jensen alpha and skewness to decide if AngioDynamics performance from the past will be repeated at some point in the near future.
  

AngioDynamics Performance

0 of 100

Over the last 90 days AngioDynamics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's technical and fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm insiders. ...more
Begin Period Cash Flow48.2 M
Total Cashflows From Investing Activities-19.3 M

AngioDynamics Relative Risk vs. Return Landscape

If you would invest  1,328  in AngioDynamics on December 23, 2022 and sell it today you would lose (121.00)  from holding AngioDynamics or give up 9.11% of portfolio value over 90 days. AngioDynamics is currently does not generate positive expected returns and assumes 2.8762% risk (volatility on return distribution) over the 90 days horizon. In different words, 25% of stocks are less volatile than AngioDynamics, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days AngioDynamics is expected to under-perform the market. In addition to that, the company is 3.01 times more volatile than its market benchmark. It trades about -0.04 of its total potential returns per unit of risk. The NYSE Composite is currently generating roughly -0.05 per unit of volatility.

AngioDynamics Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for AngioDynamics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as AngioDynamics, and traders can use it to determine the average amount a AngioDynamics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0406

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsANGO

Estimated Market Risk

 2.88
  actual daily
 25 
75% of assets are more volatile
2525

Expected Return

 -0.12
  actual daily
 
Most of other assets have higher returns
00

Risk-Adjusted Return

 -0.04
  actual daily
 
Most of other assets perform better
00
Based on monthly moving average AngioDynamics is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AngioDynamics by adding it to a well-diversified portfolio.

AngioDynamics Fundamentals Growth

AngioDynamics Stock prices reflect investors' perceptions of the future prospects and financial health of AngioDynamics, and AngioDynamics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AngioDynamics Stock performance.

About AngioDynamics Performance

To evaluate AngioDynamics Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when AngioDynamics generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare AngioDynamics Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand AngioDynamics market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents AngioDynamics's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2023
Effect of Exchange Rate Changes on Cash-466.2 K-478.5 K
Return on Investment(7.20) (7.39) 
Return on Average Assets(0.0432) (0.0466) 
Return on Average Equity(0.06) (0.06) 
Return on Invested Capital(0.21) (0.23) 
Return on Sales(0.08) (0.09) 

Things to note about AngioDynamics performance evaluation

Checking the ongoing alerts about AngioDynamics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AngioDynamics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
AngioDynamics generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 316.22 M. Net Loss for the year was (26.55 M) with profit before overhead, payroll, taxes, and interest of 164.93 M.
AngioDynamics currently holds about 24.56 M in cash with (7.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31.
AngioDynamics has a poor financial position based on the latest SEC disclosures
Over 96.0% of the company shares are held by institutions such as insurance companies
Latest headline from benzinga.com: Decibel Therapeutics Appoints Matthew Kapusta to its Board of Directors
Evaluating AngioDynamics' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate AngioDynamics' stock performance include:
  • Analyzing AngioDynamics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AngioDynamics' stock is overvalued or undervalued compared to its peers.
  • Examining AngioDynamics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating AngioDynamics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of AngioDynamics' management team can help you assess the company's leadership.
  • Pay attention to analyst opinions and ratings of AngioDynamics' stock. These opinions can provide insight into AngioDynamics' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating AngioDynamics' stock performance is not an exact science, and many factors can impact AngioDynamics' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Trending Equities. To learn how to invest in AngioDynamics Stock please use our How to Invest in AngioDynamics guide. Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for AngioDynamics Stock analysis

When running AngioDynamics price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.84) 
Revenue Per Share
8.353
Quarterly Revenue Growth
0.091
Return On Assets
(0.0247) 
Return On Equity
(0.08) 
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine AngioDynamics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.